SYENF Syngenta AG featured news, full reports, and detailed charts
Syngenta AG (SYENF/SYENF.PK) Wrap Up:
Syngenta AG, an agribusiness company, engages in the discovery, development, manufacture, and marketing of a range of products designed to improve crop yields and food quality worldwide. It operates in three segments: Crop Protection, Seeds, and Business Development. The Crop Protection segment offers herbicides primarily for corn, cereals, soybean, and rice; fungicides for cereals, fruits, grapes, rice, soybean, and vegetables; insecticides for fruits, vegetables, and field crops; seed care primarily in corn, soybean, cereals, and cotton; and professional products, such as products for public health and products for turf and ornamentals. The company markets these products through independent distributors and dealers, agricultural consultants, and growers. The Seeds segment develops, produces, and markets seeds and plants based on advanced genetics and related technologies. This segment offers approximately 200 product lines and approximately 6,000 varieties, including vegetables, flowers, corn, soybean, sugar beet, and sunflower. The company markets these products worldwide primarily under NK, Golden Harvest, Garst, Hilleshog, S&G, Rogers, Zeraim Gedera, and Fischer brand names. The Business Development segment offers a sugar beet suitable for cultivation in tropical climates, such as India. It also has various products under development, including VipCot cotton for improved resistance to insects; and amylase corn for use in the production of bio ethanol. The company was founded in 1999 and is headquartered in Basel, Switzerland. Syngenta AG operates independently of Novartis AG and AstraZeneca plc as of November 13, 2000.Syngenta AG (SYENF:Pink OTC Markets Inc)
Snapshot of Syngenta AG (SYENF)
|
OPEN
--
|
PREVIOUS CLOSE
$263.50
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
11/18/09 - $263.50
|
52 WEEK LOW
11/21/08 - $140.00
|
|
|
MARKET CAP
24.5B
|
AVERAGE VOLUME 3 mo
4.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
93.0M
|
|
|
SYENF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
related news
related news
SYENF Top Compensated Officers
Executives, Board Directors
Key developments for Syngenta AG (SYENF)
Syngenta AG announced that its genetically modified corn traits MIR162 and Bt11xGA21 are now fully approved for cultivation in Brazil. This follows the approval by the National Biosafety Committee and the thirty day clearance period. The approval of these advanced technologies will offer Brazilian growers increased productivity, higher grain quality and reduced production costs. The efficacy and broad spectrum of MIR162 make it the most advanced technology available to control the fall army worm, the main insect threat to corn in Brazil. The stacked corn trait Bt11xGA21 offers higher value and convenience for growers through combined insect resistance and herbicide tolerance.
Syngenta AG reported sales results for the nine months of 2009. In the first nine months of 2009, sales were unchanged at constant exchange rates at $8.7 billion compared to $9.572 billion for the same period of last year.
Syngenta AG said that the company is more optimistic about its prospects for 2010 and sees a return to growth. The company did not rule out making a big acquisition. Syngenta again reiterated that it could consider bidding for Dow Chemical's agricultural sciences unit if it were put up for sale. The company could also consider returning cash to shareholders or go after more acquisitions. Chief Executive of Syngenta Mike Mack said, “Our history also has us sometimes returning cash to shareholders in the years where we're not otherwise competing with growth projects. So we'll take a look at all of those things.”
SYENF Competitors
| Company | Last | Change |
| FMC Corp | $56.33 USD | -0.16 |
| Monsanto Co | $80.08 USD | +0.51 |
| Nufarm Ltd | A$11.90 AUD | -0.10 |
| Sumitomo Chemical Company Limited | ¥354.00 JPY | +9.00 |
| The Scotts Miracle-Gro Co | $40.87 USD | -0.29 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | SYENF | Industry Range |
| Price/Earnings | 17.8x |
|
| Price/Sales | 2.2x |
|
| Price/Book | 3.5x |
|
| Price/Cash Flow | 17.6x |
|
| TEV/Sales | 1.8x |
|
|
SYENF |
||
SYENF transactions
| Type Date |
Target |
|
Merger/Acquisition
August 6, 2009 |
Monsanto Company, Global Hybrid Sunflower Seed Business |
|
Merger/Acquisition
June 11, 2009 |
Circle One Global, Inc. |
More Recent News About Syngenta AG
More news for SYENF
Monsanto Backs French Biotech Firm
LONDON -- Cellectis, a $150 million French biotechnology company that specializes in "gene clipping"--or the targeted removal, insertion or manipulation of genetic material--has just landed its biggest backer yet in the shape of Monsanto. The $45 billion agribusiness leviathan is paying Cellectis 3 million euros ($4.3 million) upfront to access the French firm's proprietary technology, and is also buying a 1% stake for 1 million euros ($1.4 million) to beef up its investment.Why is Monsanto ( MON - news - people Forbes that unlike previous trial-and-error research in agriculture, Cellectis' technology could pinpoint a gene and remove it entirely, or do the opposite and even "stack" multiple genes to alter a plant in radically different ways.As an example, rice could be altered to conserve water in a dry environment by removing the gene related to the opening of the crop's pores. The process is sometimes called "gene clipping," and the instrument known as "gene scissors"--though the specific term is a "meganuclease."Monsanto is only the latest agribusiness company to sign a deal to license Cellectis' technology. Big players including BASF ( BASFY - news ...Click here to read the whole Article (external link)